Fernanda Danielle Maria Gonçalves

Fernanda Danielle Maria Gonçalves

Auto-generated profile, based on publicly available information

Fernanda Danielle Maria Gonçalves

Centro de Diagnóstico Veterinário

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2022 in Brazilian Journal of Veterinary Research and Animal Science
Verified
Journal Article
Open access
PDF file
JSJessyca Vanderlei de Albuquerque Souza
Jessyca Vanderlei de Albuquerque Souza
FGFernanda Danielle Maria Gonçalves
Fernanda Danielle Maria Gonçalves
ALArnaldo Cesar Oliveira Gomes Lira-Junior
Arnaldo Cesar Oliveira Gomes Lira-Junior
PEPierre Barnabé Escodro
Pierre Barnabé Escodro
DCDiogo Ribeiro Câmara
Diogo Ribeiro Câmara
MNMARCIA KIKUYO NOTOMI
MARCIA KIKUYO NOTOMI
Chemotherapy agents have some undesirable and non-selective cytostatic effects. Considering that kidneys are vulnerable to drug-induced toxicity, this study evaluated renal injury caused by vincristine sulfate (VS) in 12 female dogs diagnosed with transmissible venereal tumor (TVT). The animals were treated with VS (0.025 mg/kg IV) every 7 days for 4 weeks. During treatment, the animals were subjected to clinical examination, blood count, serum measurement of symmetric dimethylarginine (SDMA), blood urea nitrogen (BUN), creatinine, alanine aminotransferase, and alkaline phosphatase. In addition, urinalysis and urinary gamma-glutamyl transferase (GGT) measurements were performed. All parameters were determined three times: before beginning the treatment (T0), after 14 days (T1), and after 28 days (T2). During the study period, there were no changes in serum urea or creatinine levels, urine specific gravity, or persistent proteinuria. Furthermore, urinary GGT measurement did not indicate tubular lesions, and consistent elevation of SDMA was found in only one patient above the reference range. The results showed that weekly therapy with VS as a single agent for 28 days does not induce renal injury in most cases.